Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-23 Sale |
2024-05-28 5:01 pm |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
2,274 | $5.84 | $13,280 | 178,026 (Direct) |
View |
| 2024-05-23 Sale |
2024-05-28 5:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks |
21,626 | $5.79 | $125,215 | 833,353 (Direct) |
View |
| 2024-02-26 Purchase |
2024-02-27 4:43 pm |
OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner |
930,851 | $7.52 | $7,000,000 | 8,591,401 (Indirect) |
View |
| 2024-02-05 Sale |
2024-02-06 6:38 pm |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
5,910 | $4.86 | $28,723 | 243,689 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 6:35 pm |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
6,029 | $4.86 | $29,301 | 336,493 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 6:32 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
6,346 | $4.86 | $30,842 | 353,054 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 6:29 pm |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
6,212 | $4.86 | $30,190 | 380,356 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 6:26 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
19,642 | $4.86 | $95,460 | 1,144,601 (Indirect Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:03 pm |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
6,433 | $4.95 | $31,843 | 139,932 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:02 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
7,764 | $4.95 | $38,432 | 92,767 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:01 pm |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
6,831 | $4.95 | $33,813 | 109,218 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:01 pm |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
5,147 | $4.95 | $25,478 | 89,619 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
18,338 | $4.95 | $90,773 | 434,443 (Indirect Direct) |
View |
| 2023-12-14 Purchase |
2023-12-18 4:52 pm |
OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner |
1,538,461 | $3.25 | $4,999,998 | 7,660,550 (Indirect) |
View |
| 2023-08-30 Purchase |
2023-09-05 08:27 am |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
6,500 | $3.81 | $24,765 | 452,781 (Indirect Direct) |
View |
| 2023-07-07 Sale |
2023-07-11 8:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
832 | $4.93 | $4,102 | 100,531 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:38 pm |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
5,829 | $4.24 | $24,715 | 94,766 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:33 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
6,416 | $4.24 | $27,204 | 101,363 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:32 pm |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
6,476 | $4.24 | $27,458 | 139,387 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:31 pm |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
6,181 | $4.24 | $26,207 | 109,071 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:29 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
19,669 | $4.24 | $83,397 | 446,281 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-24 Option Award |
2024-07-26 6:38 pm |
N/A 2034-07-23 |
OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director |
48,000 | $0 | 72,000 (Direct) |
View |
| 2024-06-01 Option Award |
2024-06-04 5:28 pm |
N/A 2034-05-31 |
OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer |
566,666 | $0 | 566,666 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 8:07 pm |
N/A 2024-02-21 |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin Executive Chairman |
2,137,448 | $0 | 2,137,448 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 8:06 pm |
N/A 2024-02-21 |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
324,850 | $0 | 424,850 (Direct) |
View |
Ownership |
2024-02-26 8:02 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
0 | $0 | 100,000 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:38 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
159,980 | $0 | 243,689 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:35 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
233,304 | $0 | 336,493 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:32 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
266,633 | $0 | 353,054 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:29 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
246,636 | $0 | 380,356 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:26 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
729,800 | $0 | 1,144,601 (Direct) |
View |
| 2023-08-02 Option Award |
2023-08-18 8:45 pm |
N/A 2033-08-01 |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director |
17,350 | $0 | 17,350 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 5:18 pm |
N/A 2033-07-09 |
OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:09 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director |
48,000 | $0 | 96,464 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:08 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director |
48,000 | $0 | 61,433 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:05 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director |
48,000 | $0 | 56,933 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:05 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director |
48,000 | $0 | 156,402 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:03 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director |
48,000 | $0 | 56,933 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:02 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director |
48,000 | $0 | 95,933 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:36 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
177,777 | $0 | 233,928 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:35 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
222,223 | $0 | 281,919 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:34 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
272,223 | $0 | 324,446 (Direct) |
View |